Implied PID Analyst Target Price: $23

The Invesco International Dividend Achievers ETF (PID) carries an implied analyst target price of $23.36, suggesting a 10.47% upside from its recent $21.15 trading price, based on the weighted average of its underlying holdings' analyst targets. This potential upside is significantly influenced by key constituents such as PLDT Inc (PHI), Sanofi (SNY), and Coca-Cola FEMSA SAB de CV (KOF), which together comprise 8.12% of the ETF and exhibit individual analyst target upsides of 59.08%, 26.94%, and 25.30% respectively. While these figures indicate substantial appreciation potential, the article cautions that investors should conduct further research to validate the justification and recency of these analyst targets.

Analysis

Analysis of the Invesco International Dividend Achievers ETF (PID) reveals an implied 10.47% upside to an aggregate analyst target price of $23.36 per unit, from its recent trading price of $21.15. This potential appreciation is heavily influenced by a few key underlying holdings which exhibit substantially higher analyst-projected returns. Specifically, PLDT Inc. (PHI), Sanofi (SNY), and Coca-Cola FEMSA (KOF) collectively account for 8.12% of the ETF's weight and carry analyst target upsides of 59.08%, 26.94%, and 25.30%, respectively. While these figures present a moderately positive outlook, the analysis is inherently speculative, as the source itself questions the validity and recency of these targets. The significant gap between current prices and analyst targets could reflect strong future optimism or, conversely, signal a risk of future downgrades if the targets are outdated, necessitating further due diligence from investors.

Key Decisions for Investors

• Investors should scrutinize the fundamental catalysts and valuation models justifying the high analyst price targets for key holdings PLDT Inc. (PHI), Sanofi (SNY), and Coca-Cola FEMSA (KOF), as their performance disproportionately influences the ETF's calculated upside.
• Consider the 10.47% implied upside for PID as a preliminary screening metric, but weigh it against the risk that the underlying analyst targets may be overly optimistic or lagging recent market or company-specific developments.